These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8466163

  • 21. Maternal serum CA125 is not a second trimester marker for Down's syndrome.
    Spencer K.
    Ann Clin Biochem; 1991 May; 28 ( Pt 3)():299-300. PubMed ID: 1831336
    [No Abstract] [Full Text] [Related]

  • 22. Current state of second trimester screening for Down's syndrome.
    Canick JA.
    J Med Screen; 1998 May; 5(3):113-4. PubMed ID: 9795868
    [No Abstract] [Full Text] [Related]

  • 23. Elevated second-trimester maternal serum inhibin A levels in Asian pregnancies with fetal down syndrome and other chromosomal abnormalities.
    Hsu JJ, Chiang CH, Hsieh CC, Hsieh TT.
    Fetal Diagn Ther; 2003 May; 18(2):105-10. PubMed ID: 12576745
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies.
    Erickson JA, Ashwood ER, Gin CA.
    Arch Pathol Lab Med; 2004 Apr; 128(4):415-20. PubMed ID: 15043467
    [Abstract] [Full Text] [Related]

  • 25. A technical and clinical evaluation of a new assay for inhibin A and its use in second trimester Down syndrome screening.
    Wilson G, Liitti P, Pölönen T, Sairanen M, Spencer K.
    Clin Chem Lab Med; 2016 Sep 01; 54(9):1473-9. PubMed ID: 26887039
    [Abstract] [Full Text] [Related]

  • 26. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG.
    Prenat Diagn; 1996 Feb 01; 16(2):143-53. PubMed ID: 8650125
    [Abstract] [Full Text] [Related]

  • 27. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M, Nørgaard-Pedersen B.
    Clin Genet; 2005 Jul 01; 68(1):35-9. PubMed ID: 15952984
    [Abstract] [Full Text] [Related]

  • 28. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
    Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM.
    Prenat Diagn; 1996 Dec 01; 16(12):1095-100. PubMed ID: 8994244
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Second test for Down's syndrome is recommended for NHS.
    Wise J.
    BMJ; 2016 Jan 15; 352():i285. PubMed ID: 26773062
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibin-A concentrations between 14 and 22 weeks of gestation.
    Wald NJ, Huttly WJ, Bestwick JP.
    Prenat Diagn; 2008 Apr 15; 28(4):360-1. PubMed ID: 18330861
    [No Abstract] [Full Text] [Related]

  • 33. Second-trimester Down's syndrome serum screening: double, triple or quadruple marker testing?
    Harrison G, Goldie D.
    Ann Clin Biochem; 2006 Jan 15; 43(Pt 1):67-72. PubMed ID: 16390612
    [Abstract] [Full Text] [Related]

  • 34. Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum.
    Yu B, Zhang B, Wang J, Wang QW, Huang RP, Yang YQ, Shao SH.
    Exp Biol Med (Maywood); 2012 May 15; 237(5):530-9. PubMed ID: 22678011
    [Abstract] [Full Text] [Related]

  • 35. Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.
    Lambert-Messerlian GM, Canick JA.
    Semin Reprod Med; 2004 Aug 15; 22(3):235-42. PubMed ID: 15319826
    [Abstract] [Full Text] [Related]

  • 36. Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening.
    Lambert-Messerlian GM, Palomaki GE, Eklund EE, Kloza EM, Neveux LM, Phipps MG, Canick JA.
    J Med Screen; 2012 Dec 15; 19(4):164-70. PubMed ID: 23277614
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
    Wald NJ, Watt HC, George L.
    Prenat Diagn; 1996 Oct 15; 16(10):923-6. PubMed ID: 8938061
    [Abstract] [Full Text] [Related]

  • 39. Maternal serum total activin A in pregnancies affected with fetal Down's syndrome.
    Lambert-Messerlian GM, Canick JA, Palomaki GE.
    J Med Screen; 1996 Oct 15; 3(4):217. PubMed ID: 9041489
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.